Visceral leishmaniasis in renal transplant recipients: clinical aspects, diagnostic problems, and response to treatment (Q40420000)

20 September 2017

Visceral leishmaniasis in renal transplant recipients: clinical aspects, diagnostic problems, and response to treatment (English)

1 reference

20 September 2017

visceral leishmaniasis

1 reference

C M C Oliveira

1

1 reference

20 September 2017

M L M B Oliveira

2

1 reference

20 September 2017

S C A Andrade

3

1 reference

20 September 2017

E S Girão

4

1 reference

20 September 2017

C N Ponte

5

1 reference

20 September 2017

M U Mota

6

1 reference

20 September 2017

P F C B C Fernandes

7

1 reference

20 September 2017

H H Campos

8

1 reference

20 September 2017

R M Esmeraldo

9

1 reference

20 September 2017

J B Evangelista

10

1 reference

20 September 2017

language of work or name

English

0 references

publication date

1 April 2008

1 reference

Transplantation Proceedings

20 September 2017

1 reference

20 September 2017

40

1 reference

20 September 2017

755-760

1 reference

20 September 2017

3

1 reference

Visceral leishmaniasis in immunocompromised hosts

20 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.02.039

Sensitivity of bone marrow aspirates in the diagnosis of visceral leishmaniasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.02.039

Comparison of conventional methods for diagnosis of visceral leishmaniasis in children of the Center-West Region of Brazil.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.02.039

Serodiagnosis of leishmaniasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.02.039

An atypical course of visceral leishmaniasis (Kala-azar) in a liver transplant recipient

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.02.039

The utility of bone marrow examination in renal transplantation: nine years of experience from north India.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.02.039

Visceral leishmaniasis (Kala-Azar) in transplant recipients: case report and review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.02.039

Visceral Leishmaniasis in renal transplant recipients: is it still a challenge to the nephrologist?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.02.039

Visceral leishmaniasis in organ transplant recipients: 11 new cases and a review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.02.039

Visceral leishmaniasis (kala-azar) in solid organ transplantation: report of five cases and review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.02.039

Prophylaxis of visceral leishmaniasis in human immunodeficiency virus-infected patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.02.039

Treatment of visceral leishmaniasis with pentavalent antimony and interferon gamma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.02.039

Visceral leishmaniasis in renal transplant recipients: successful treatment with liposomal amphotericin B (AmBisome)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.02.039

Antileishmanial activity of liposome-encapsulated amphotericin B in hamsters and monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.02.039

Visceral leishmaniasis in immunocompromised patients with and without AIDS: a comparison of clinical features and prognosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.02.039

Treatment of visceral leishmaniasis in HIV-infected patients: a randomized trial comparing meglumine antimoniate with amphotericin B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.02.039

Oral miltefosine for Indian visceral leishmaniasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.02.039

10.1016/J.TRANSPROCEED.2008.02.039

7 January 2021

Identifiers

DOI

1 reference

20 September 2017

1 reference